TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
INBX

Inhibrx Biosciences, Inc.

Healthcare · Biotechnology

99.60$ -0.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow INBX
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.50 -0.65 -0.85 -0.88 -1.90 -2.11 -2.87 -4.10 -13.43 -8.38
0.01 0.01 0.02 0.03 0.04 0.03 0.03 0.03 0.16 0.16
0.02 0.04 0.09 0.11 0.20 0.40 0.51 0.53 4.04 0.72
-0.17 0.03 0.16 0.10 0.50 -0.46 0.08 0.33 3.60 -0.49
0.01 0.05 0.05 0.05 0.05 0.02 0.02 0.10 0.18 0.00
-0.01 -0.05 -0.05 -0.05 -0.05 -0.02 -0.02 -0.10 -0.18 0.00
– 0.05 0.03 – – – – – – –
– – – – – -0.01 – – – –
– – – – – – – – 0.00 6.45
0.79 0.47 0.49 1.19 6.59 2.20 6.45 4.29 4.95 6.55
0.29 -0.23 -0.42 0.26 4.64 0.07 3.55 0.09 -8.66 -1.83
-0.50 -0.70 -0.91 -0.93 -1.95 -2.14 -2.89 -4.20 -13.61 -8.38

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?